Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Debatosh Datta"'
Autor:
Debatosh Datta, Rajveer Singh, Ravichandiran Velayutham, Arka Bhattacharya, Ujjwayini Ray, Sarbani Dasgupta, Soma Dutta, Aditi Saha, Debabrata Roy, Srinika Ghosh, Somasundaram Arumugam, Pallab Datta, N K Ganguly
Publikováno v:
Apollo Medicine, Vol 19, Iss 4, Pp 251-255 (2022)
Introduction: SARS-CoV-2 respiratory infection leads to two-layered pathology in time (a) immediate pathology and recovery or fatal ending and (b) long periods of remission followed by unexplained clinical expressions involving one or more systems wi
Externí odkaz:
https://doaj.org/article/237b06c1c9854e58b300d6adcdbf9ef5
Publikováno v:
Apollo Medicine, Vol 17, Iss 5, Pp 50-54 (2020)
This is an indicative mini-review on possible new therapeutics for COVID-19 with preexisting ischemic morbidities. The review highlights a new supportive therapeutic approach where lysine-induced controlled vascular organization (angiogenesis) has be
Externí odkaz:
https://doaj.org/article/54c901411eaf4b558ef03b1af45118cd
Autor:
Rajveer Singh, Velayutham Ravichandiran, Dipanjan Ghosh, Ujjaini Ray, Sarbani Dasgupta, Soma Dutta, Aditi Saha, Debabrota Roy, Srinika Ghosh, A. Somasundaram, Pallab Dutta, N K Ganguly, Debatosh Datta
Cell-mediated immunity (CMI), which includes T-cells (both T helper and cytotoxic), is critical for effective antiviral defenses against coronavirus disease-2019 (COVID-19). To better understand the immunological characteristics of CD markers on T-ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95b096987f0a0154578eded34b55b541
https://doi.org/10.1101/2022.07.02.22276875
https://doi.org/10.1101/2022.07.02.22276875
Autor:
Debatosh Datta, Suyash Pant, Devendra Kumar Dhaked, Somasundaram Arumugam, Rudra Chakravarti, Ravichandiran Velayutham, Pallab Datta
Publikováno v:
Journal of Pharmacy and Pharmacology Research.
Autor:
Debatosh Datta, Suyash Pant, Devendra Kumar Dhaked, Somasundaram Arumugam, Ravichandiran Velayutham, Pallab Datta
Upper and lower respiratory pathogens – both microbes and viruses –are responsible for very high morbidity, man-hour loss, residual long term clinical conditions and even mortality. In india only, high incidence of annual respiratory infections
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4547ab08b3079d9e08ce2a6884d3b776
https://doi.org/10.1101/2021.12.01.470353
https://doi.org/10.1101/2021.12.01.470353
Publikováno v:
Apollo Medicine, Vol 17, Iss 5, Pp 50-54 (2020)
This is an indicative mini-review on possible new therapeutics for COVID-19 with preexisting ischemic morbidities. The review highlights a new supportive therapeutic approach where lysine-induced controlled vascular organization (angiogenesis) has be
Autor:
Sujoy Kar, Aritri Bir, Joy Basu, Priyanshu Verma, Anindita Banerjee, Sujoy Kumar Samanta, Debatosh Datta
In-vivo angiogenesis process is highly conserved and is mediated through a family of peptides having VEGF-A as the lead member. A respective receptor family comprising of members VEGFR-1, 2, 3 gets expressed on the endothelial cell membrane of the va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abed4c814dc89a5f724a73b0f3481af1
https://doi.org/10.1101/077677
https://doi.org/10.1101/077677
Publikováno v:
IndraStra Global.
Rheumatic heart disease is a significant clinical entity in young children, especially in the developing world. One of the major long-term effects of ill managed rheumatic fever is irreversible damage to the cardiac valve leaflets, primarily on the l
Publikováno v:
Apollo Medicine; Covid Special, Vol. 17, p50-54, 5p
Publikováno v:
Electro- & Magnetobiology. Nov2001, Vol. 20 Issue 3, p263. 18p.